---
date created: 2024-11-18
tags:
  - meds
---
**Class:**
- Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)

**Mechanism of Action (MOA):**
- Inhibits the reuptake of serotonin and norepinephrine, increasing their levels in the synaptic cleft.

**Indications/Uses:**
- Major Depressive Disorder (MDD)
- Generalized Anxiety Disorder (GAD)
- Social Anxiety Disorder (SAD)
- Panic Disorder

**Side Effects:**
- Nausea
- Dizziness
- Insomnia
- Dry mouth
- Sweating

**Adverse Effects:**
- Serotonin Syndrome
- Hypertension
- Suicidal thoughts (especially in young adults and adolescents)

**Nursing Teaching and Implications:**
- Monitor blood pressure regularly.
- Educate about potential delay in therapeutic effects (several weeks).
- Advise to avoid alcohol.
- Encourage reporting of any worsening depression or suicidal thoughts.

**Contraindications:**
- Concurrent use with MAO inhibitors
- Known hypersensitivity to venlafaxine